Child Health and Infection With Low Density (CHILD) Malaria
Status:
Not yet recruiting
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
This trial will assess the long-term health and socioeconomic impact of interventions
targeting low-density malaria infection (LMI) among children in Tanzania
Phase:
Phase 3
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Chan Zuckerberg Biohub Ifakara Health Institute National Institute of Allergy and Infectious Diseases (NIAID) Stanford University Swiss Tropical & Public Health Institute
Treatments:
Artemether Artemether, Lumefantrine Drug Combination Lumefantrine